Seagen Inc. (SGEN)

Last Price:  

Company Description

Seagen Inc. is a biotechnology company. It discovers, develops and commercializes transformative cancer medicines. The company operates principally in California, Canada, Switzerland and the European Union. Seagen Inc., formerly known as Seattle Genetics Inc., is headquartered in the Seattle.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $2.18B
Net Income (Most Recent Fiscal Year) $613.67M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) 53.84
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 13.40
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 9.42
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 47.73
Pre-Tax Margin (Trailing 12 Months) 25.14%
Net Margin (Trailing 12 Months) 25.06%
Return on Equity (Trailing 12 Months) 19.02%
Return on Assets (Trailing 12 Months) 16.03%
Current Ratio (Most Recent Fiscal Quarter) 7.14
Quick Ratio (Most Recent Fiscal Quarter) 6.77
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) 2.16
Book Value per Share (Most Recent Fiscal Quarter) $19.28
Earnings per Share (Most Recent Fiscal Quarter) $-0.47
Earnings per Share (Most Recent Fiscal Year) $3.30
Diluted Earnings per Share (Trailing 12 Months) $3.26
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 181.93M
Free Float 131.72M
Market Capitalization $31.93B
Average Volume (Last 20 Days) 0.75M
Beta (Past 60 Months) 0.83
Percentage Held By Insiders (Latest Annual Proxy Report) 27.60%
Percentage Held By Institutions (Latest 13F Reports) 88.20%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%